Terremoto Biosciences
Terremoto Biosciences62About
What does Terremoto Biosciences do?
Terremoto Biosciences is a biotechnology company redefining small-molecule therapeutics through cutting-edge medicinal chemistry and novel covalency technologies. They engineer next-generation oral medicines designed for superior efficacy and patient outcomes, aiming to set new class standards for targets with historically narrow therapeutic windows. The company seeks to deliver transformative therapies to patients by pursuing "undruggable" targets.
What is Terremoto Biosciences's revenue?
StartupHub estimates Terremoto Biosciences's annual revenue at $8.4M (range $4.5M to $23.3M, 68% confidence), based on comparable companies in the sector.
What is Terremoto Biosciences's valuation?
StartupHub estimates Terremoto Biosciences's effective valuation at $457.9M (range $270.0M to $648.0M, 24% confidence), based on comparable companies in the sector.
How much funding has Terremoto Biosciences raised?
Terremoto Biosciences has raised a total of $108M in funding. The most recent round on record is Series C.
Where is Terremoto Biosciences headquartered?
Terremoto Biosciences is headquartered in South San Francisco, California, USA.
What industry does Terremoto Biosciences operate in?
Terremoto Biosciences operates in Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare.
How many employees does Terremoto Biosciences have?
Terremoto Biosciences has approximately 54 people on record.
No comments yet. Be the first to share your take.